BNP PARIBAS FINANCIAL MARKETS - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 282 filers reported holding BLUEBIRD BIO INC in Q3 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$652,086
-40.0%
214,502
-35.1%
0.00%0.0%
Q2 2023$1,086,677
-44.2%
330,297
-46.1%
0.00%
-66.7%
Q1 2023$1,947,725
+34.1%
612,492
+191.9%
0.00%
+50.0%
Q4 2022$1,452,197
-99.9%
209,855
-36.3%
0.00%
-33.3%
Q3 2022$2,085,292,000
+171.0%
329,430
+77.2%
0.00%
+200.0%
Q2 2022$769,605,000
-38.8%
185,895
-28.3%
0.00%
-50.0%
Q1 2022$1,257,668,000
-57.6%
259,313
-12.7%
0.00%
-50.0%
Q4 2021$2,966,980,000
+57.0%
296,995
+200.3%
0.00%
+33.3%
Q3 2021$1,889,711,000
-22.7%
98,886
+29.4%
0.00%0.0%
Q2 2021$2,443,848,000
+60.3%
76,418
+51.1%
0.00%
+50.0%
Q1 2021$1,524,957,000
-38.1%
50,579
-11.1%
0.00%
-60.0%
Q4 2020$2,462,106,000
+51.0%
56,901
+88.3%
0.01%
+150.0%
Q3 2020$1,630,531,000
+47.2%
30,223
+66.6%
0.00%0.0%
Q2 2020$1,107,510,000
-24.1%
18,144
-42.9%
0.00%
-33.3%
Q1 2020$1,460,103,000
+18.2%
31,769
+125.6%
0.00%
+50.0%
Q4 2019$1,235,783,000
-79.0%
14,083
-78.0%
0.00%
-80.0%
Q3 2019$5,872,073,000
+133.0%
63,952
+222.7%
0.01%
+100.0%
Q2 2019$2,520,595,000
+25.5%
19,816
+55.2%
0.01%
+25.0%
Q1 2019$2,008,317,000
+9.5%
12,765
-30.9%
0.00%0.0%
Q4 2018$1,833,514,000
+1.5%
18,483
+49.5%
0.00%
+33.3%
Q3 2018$1,805,582,000
+6.2%
12,367
+14.2%
0.00%0.0%
Q2 2018$1,700,239,000
-53.2%
10,833
-49.1%
0.00%
-57.1%
Q1 2018$3,633,048,000
+103.0%
21,277
+111.7%
0.01%
+133.3%
Q4 2017$1,789,727,000
+139.4%
10,049
+84.6%
0.00%
+50.0%
Q3 2017$747,733,000
+39.2%
5,444
+6.5%
0.00%0.0%
Q2 2017$537,226,000
+610.3%
5,114
+514.7%
0.00%
Q1 2017$75,629,000
-57.2%
832
-71.0%
0.00%
-100.0%
Q4 2016$176,832,000
-15.4%
2,866
-7.1%
0.00%0.0%
Q3 2016$209,034,000
+229.6%
3,084
+110.5%
0.00%
Q2 2016$63,420,000
+268.4%
1,465
+261.7%
0.00%
Q1 2016$17,213,000
-66.2%
405
-49.0%
0.00%
Q4 2015$50,990,000
-73.6%
794
-64.9%
0.00%
Q3 2015$193,257,000
+64.2%
2,259
+223.2%
0.00%
Q2 2015$117,691,000
+109.1%
699
+50.0%
0.00%
Q1 2015$56,279,000
+22.6%
466
-63.6%
0.00%
Q3 2014$45,891,000
+604.1%
1,279
+656.8%
0.00%
Q2 2014$6,518,000
+789.2%
169
+356.8%
0.00%
Q1 2014$733,000
+16.5%
37
+23.3%
0.00%
Q4 2013$629,000300.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders